House Publications
The Debates are the report—transcribed, edited, and corrected—of what is said in the House. The Journals are the official record of the decisions and other transactions of the House. The Order Paper and Notice Paper contains the listing of all items that may be brought forward on a particular sitting day, and notices for upcoming items.
For an advanced search, use Publication Search tool.
If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.
|
|
|
Notice PaperNo. 102 Thursday, March 29, 2012 10:00 a.m. |
|
|
|
|
Introduction of Government Bills |
|
Introduction of Private Members' Bills |
|
Notices of Motions (Routine Proceedings) |
|
| March 28, 2012 — Ms. Crowder (Nanaimo—Cowichan) — That the Fourth Report of the Standing Committee on Human Resources, Skills and Social Development and the Status of Persons with Disabilities, presented on Wednesday, March 28, 2012, be concurred in. |
| Concurrence motion — may not be moved before either a comprehensive response has been tabled or Thursday, July 26, 2012, whichever shall come first, pursuant to Standing Order 109. |
|
|
| March 28, 2012 — Mr. Harris (St. John's East) — That the Seventh Report of the Standing Committee on Justice and Human Rights, presented on Wedensday, March 28, 2012, be concurred in. |
| Concurrence motion — may not be moved before either a comprehensive response has been tabled or Thursday, July 26, 2012, whichever shall come first, pursuant to Standing Order 109. |
|
|
| March 28, 2012 — Ms. Chow (Trinity—Spadina) — That the Fourth Report of the Standing Committee on Public Accounts, presented on Wedensday, March 28, 2012, be concurred in. |
| Concurrence motion — may not be moved before either a comprehensive response has been tabled or Thursday, July 26, 2012, whichever shall come first, pursuant to Standing Order 109. |
Questions |
|
| Q-5582 — March 28, 2012 — Ms. Foote (Random—Burin—St. George's) — With regard to the closure of the Maritime Rescue Sub-Centre in St. John’s: (a) what are the dates of all communication on this subject between any official of the federal government and any official of the provincial government of Newfoundland and Labrador; (b) what was the medium of such communication; (c) who initiated the communication; (d) who was the recipient or intended recipient; and (e) what are the associated file or reference numbers associated with any such communication? |
| Q-5592 — March 28, 2012 — Ms. Boutin-Sweet (Hochelaga) — With regard to Human Resources and Skills Development Canada (HRSDC): (a) what are the names of the Department’s skills programs; and (b) for each skills program in (a), what is (i) the target population, (ii) the funding recipient (i.e., provinces and territories or organizations), (iii) the budget for each fiscal year from 2005-2006 to 2012-2013, broken down by operating expenses and transfer payments, (iv) the projected budget for fiscal years 2013-2014, 2014-2015, and 2015-2016, broken down by operating expenses and transfer payments, (v) the number of applications received annually for funding, broken down by the number of applications accepted and the number of applications rejected, (vi) how many HRSDC staff work on administering or evaluating the program, (vii) what evaluations have been done for the programs’ effectiveness by date and by title of report, (viii) what are the granting criteria? |
| Q-5602 — March 28, 2012 — Ms. Boutin-Sweet (Hochelaga) — With regard to government funding allocated within the constituency of Hochelaga for every fiscal year from 2004-2005 to 2012-2013: (a) what is the total amount of funding by (i) department, (ii) agency, (iii) other government entity, (iv) program; and (b) how many jobs are a direct result of this funding, including both (i) full-time jobs, (ii) part-time jobs? |
| Q-5612 — March 28, 2012 — Mr. Patry (Jonquière—Alma) — With regard to the Employment Insurance (EI) program and its administration: (a) how many overpayments have been made annually for the past five fiscal years by number and by amount, broken down by (i) region/province, (ii) year, (iii) misrepresented versus non-misrepresented cases; (b) how many overpayments have been collected annually for the past five fiscal years by number and by amount, broken down by (i) region/province, (ii) year, (iii) misrepresented versus non-misrepresented cases; (c) how many overpayments have been written off annually for the last five fiscal years by number and by amount, broken down by (i) region/province, (ii) year, (iii) misrepresented versus non-misrepresented cases; (d) how many EI cases have been adjudicated annually for the past five years, broken down by (i) region/province, (ii) year, (iii) misrepresented versus non-misrepresented cases; (e) what is the average caseload for EI inspectors annually for the past five fiscal years, broken down by (i) region/province, (ii) year, (iii) misrepresented versus non-misrepresented cases; (f) what is the average caseload for EI adjudicators annually for the past five fiscal years, broken down by (i) region/province, (ii) year, (iii) misrepresented versus non-misrepresented cases; (g) what is the EI Workload Status annually for the past five fiscal years, broken down by (i) region/province, (ii) year, (iii) total case intake, (iv) number of cases pending, (v) number of cases pending more than 29 days; and (h) excluding those on parental leave, what is the number of Service Canada employees on long-term disability leave in total and broken down by (i) EI call centres, (ii) EI processing centres? |
| Q-5622 — March 28, 2012 — Ms. Duncan (Etobicoke North) — With respect to clinical trials for chronic cerebrospinal venous insufficiency (CCSVI): (a) what was the deadline for receiving applications for clinical trials for CCSVI, (i) has the application process closed; (b) how many applications were received, and, for each application received, (i) from what institution and country was it received, (ii) are the researchers who submitted the application practiced in the diagnosis and treatment of CCSVI; (c) why was it decided that an international review panel was needed to assess applications for clinical trials; (d) what was the specific process for and who was involved in choosing the members of the international review panel; (e) who had the ultimate decision-making authority on the appointments to the international review panel; (f) has the international review panel been chosen, and, if so, (i) who is on the panel, (ii) why was each member chosen, (iii) for each member, is he or she practiced in the diagnosis and treatment of CCSVI; (g) how will all potential conflicts of interest of members of the international review panel be (i) recorded, (ii) confirmed, (iii) publicly declared; (h) has the review process of applications begun, (i) is it in progress, (ii) by what date is the review expected to be finished; (i) what specific criteria have been established to review applications; (j) by what date is an announcement expected to be made regarding the chosen research team or teams; (k) what, if any, monies have been set aside for clinical trials, (i) how was the required amount of money decided, (ii) will the monies allow for an adequate number of patients to be included to demonstrate clinical efficacy at the 0.05 level of significance; (l) what timeline is being allowed for ethics approval; (m) by what date is patient accrual expected to take place; (n) by what date are clinical trials expected to commence; and (o) what is a detailed timeline of what can be expected over the next year in terms of significant dates for clinical trials, as well as any dates for meetings regarding CCSVI? |
Notices of Motions for the Production of Papers |
|
Business of Supply |
|
Government Business |
|
Private Members' Notices of Motions |
|
Private Members' Business |
|
|
|
| 2 Response requested within 45 days |
|